Novacyt (NCYT) EUR0.0667 (CDI)
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Novacyt confirms end of Yourgene Taiwan disposal discussions
6 February 2024 12:48
(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan.
-
Novacyt taps Steve Gibson for CFO
2 January 2024 08:12
(Sharecast News) - Biotechnology group Novacyt has appointed Steve Gibson to the role of chief financial officer with immediate effect.
-
Novacyt facing delays in disposal of Yourgene Taiwan
21 December 2023 15:49
(Sharecast News) - Molecular diagnostics company Novacyt updated the market on the conditional disposal of its laboratory in Taiwan, which it acquired as part of its purchase of Yourgene Health on 8 September.
-
Novacyt to buy Yourgene Health in £16.7m deal
3 July 2023 09:07
(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.
-
UK regulator approves Novacyt Covid-19 test
6 December 2022 12:29
(Sharecast News) - Shares in clinical diagnostics specialist Novacyt sparked on Tuesday, after the UK regulator approved its latest Covid-19 test.
-
Novacyt's exsig Covid-19 PCR test receives UK approval
15 July 2022 08:43
(Sharecast News) - Clinical diagnostics group Novacyt's exsig Covid-19 Direct Real-Time PCR test has received approval from the UK's Health Security Agency.
-
Novacyt gets another Covid-19 test approved in the UK
17 February 2022 15:38
(Sharecast News) - Clinical diagnostics company Novacyt announced on Thursday that its 'PROmate' Covid-19 2G Real-Time PCR test had been approved in the UK, under the UK Health Security...
-
Novacyt gets UK approval for 'genesig' Covid-19 test
26 November 2021 08:02
(Sharecast News) - Clinical diagnostics specialist Novacyt announced on Friday thatots 'genesig' Covid-19 real-time PCR test has been approved in the UK.
-
Novacyt flags possible £3m hit from Covid test regulations change
2 November 2021 11:45
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on the availability of its Covid-19 tests in the UK on Tuesday, following the implementation of amendments to the UK Health...
-
Novacyt launches new 'Winterplex' test, lateral flow tests delayed
30 September 2021 09:37
(Sharecast News) - Clinical diagnostics specialist Novacyt issued a research and development update on Thursday, including the launch of a new CE-marked 'Winterplex' polymerase chain reaction (PCR)...
-
Novacyt swings to first-half loss amid DHSC dispute
27 September 2021 08:15
(Sharecast News) - Clinical diagnostics specialist Novacyt reported group consolidated unaudited revenue of £54m in its first half on Monday, down from £63.3m year-on-year, which excluded £40.8m of...
-
Novacyt FY revenues potentially 'materially affected' by outcome of DHSC dispute
16 September 2021 11:05
(Sharecast News) - Biotechnology company Novacyt warned on first-half revenues on Thursday as a result of its ongoing dispute with the US Department of Health and Social Care.
Company announcements Announcements
-
Liquidity Agreement and Total Voting Rights
1 March 2024 12:30
Novacyt S.A. (CDI)
-
Update on Taiwanese divestment
6 February 2024 07:00
Novacyt S.A. (CDI)
-
Liquidity Agreement and Total Voting Rights
1 February 2024 13:00
Novacyt S.A. (CDI)
-
Trading update
25 January 2024 07:00
Novacyt S.A. (CDI)
-
Liquidity Agreement and Total Voting Rights
3 January 2024 11:00
Novacyt S.A. (CDI)
-
Appointment of CFO
2 January 2024 07:00
Novacyt S.A. (CDI)
-
Update on Taiwan laboratory disposal
21 December 2023 07:00
Novacyt S.A. (CDI)
-
Liquidity Agreement and Total Voting Rights
1 December 2023 11:45
Novacyt S.A. (CDI)
-
IVDR certification for DPYD genotyping assay
7 November 2023 07:00
Novacyt S.A. (CDI)
-
Liquidity Agreement and Total Voting Rights
1 November 2023 14:30
Novacyt S.A. (CDI)
-
Result of AGM
26 October 2023 15:20
Novacyt S.A. (CDI)
-
AGM voting
11 October 2023 07:00
Novacyt S.A. (CDI)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.